MedPath

Evaluation of the effect of vaginal Progesterone in preventing preterm labor

Phase 3
Conditions
prevention of preterm labor.
Preterm labour
Registration Number
IRCT138706051096N1
Lead Sponsor
Vice Chancellor for research-Guilan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
260
Inclusion Criteria

Pregnant women were eligible to enter the trial if 1) they were between 26-36 weeks of gestation based on their LMP or sonography before 16 weeks of gestation. 2) Confirmation of premature delivery with a)uterine contractions more than 30 seconds and three or more contractions per 30 minutes established by tochodynamometer b) cervical dilatation of 0-2 cm in nulliparous and 1 -2 cm in multiparous and cervical effacement greater than 50% 3) intact membrane.
Exclusion criteria included: 1) unwillingness or inability to comply with study procedures before 36 weeks of gestation 2) lack of useful sufficient data 3) preeclampsia requiring termination of pregnancy.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prevention of preterm labour( before 37 weeks). Timepoint: 2 hours after insertion of suppository, then weekly visit. Method of measurement: control of uterine contraction.;Prevention of preterm labor (before 34 weeks). Timepoint: every two weeks. Method of measurement: Patient visits, uterine contraction determination.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath